Technical Analysis for DDDD - 4D Pharma Plc

Grade Last Price % Change Price Change
D 116.8 3.00% 3.40
DDDD closed up 3.0 percent on Friday, April 16, 2021, on 79 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical DDDD trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Narrow Range Bar Range Contraction 3.00%
NR7 Range Contraction 3.00%
Inside Day Range Contraction 3.00%
20 DMA Resistance Bearish 3.36%
MACD Bullish Signal Line Cross Bullish -1.52%
Narrow Range Bar Range Contraction -1.52%
20 DMA Resistance Bearish -0.17%
Shooting Star Candlestick Bearish -0.17%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.17%
Older End-of-Day Signals for DDDD ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High 1 day ago
Up 3% 1 day ago
Up 2% 1 day ago
Up 1% 1 day ago
10 DMA Resistance 1 day ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

4D Pharma Plc Description

4D pharma plc (4D), formerly Schosween 18 Limited, is a United Kingdom-based pharmaceutical company focusing on developing various projects targeting new therapeutic areas. The principal activity of the Company is research and development of pharmaceutical products in new live biotherapeutic areas. The Company has developed its research to build MicroRx, which is a discovery methodology that is able to rationally select those bacteria that have a precise and evolved therapeutic effect. Its MicroRx methodology offers a pipeline of approximately 10 therapeutic programs covering autoimmune diseases, central nervous system (CNS) disorders and cancer. The Company uses MicroRx to develop its programs into the clinic and has approximately two programs in patient trials. The Company focuses on immune conditions, such as pediatric Crohn's, pediatric colitis and irritable bowel syndrome.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Target Research Pharmaceutical Medicine Clinic Pipe Disease Cancer Targeting Diseases Medical Specialties Clinical Medicine Rtt Disorders Autoimmune Diseases Pharmaceutical Products Bacteria Evolve Therapeutic Effect

Is DDDD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 183.0
52 Week Low 35.377
Average Volume 2,580,069
200-Day Moving Average 107.27
50-Day Moving Average 125.19
20-Day Moving Average 117.59
10-Day Moving Average 115.38
Average True Range 8.30
ADX 9.1
+DI 19.59
-DI 17.63
Chandelier Exit (Long, 3 ATRs ) 127.69
Chandelier Exit (Short, 3 ATRs ) 126.90
Upper Bollinger Band 132.26
Lower Bollinger Band 102.93
Percent B (%b) 0.47
BandWidth 24.94
MACD Line -2.70
MACD Signal Line -2.99
MACD Histogram 0.2839
Fundamentals Value
Market Cap 153.47 Million
Num Shares 131 Million
EPS -38.20
Price-to-Earnings (P/E) Ratio -3.06
Price-to-Sales 162.13
Price-to-Book 4.03
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 124.90
Resistance 3 (R3) 124.33 121.07 123.55
Resistance 2 (R2) 121.07 119.00 121.35 123.10
Resistance 1 (R1) 118.93 117.73 120.00 119.50 122.65
Pivot Point 115.67 115.67 116.20 115.95 115.67
Support 1 (S1) 113.53 113.60 114.60 114.10 110.95
Support 2 (S2) 110.27 112.33 110.55 110.50
Support 3 (S3) 108.13 110.27 110.05
Support 4 (S4) 108.70